Onconova Therapeutics (ONTX) Tops Q1 EPS by 2c

Onconova Therapeutics (NASDAQ: ONTX) reported Q1 EPS of ($0.28), $0.02 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $60 thousand versus the consensus estimate of $100 thousand.

For earnings history and earnings-related data on Onconova Therapeutics (ONTX) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
• InspireMD (NSPR) Tops Q2 EPS by 1c